294 related articles for article (PubMed ID: 35397522)
1. Ten-year atherosclerosis cardiovascular disease (ASCVD) risk score and its components among an Iranian population: a cohort-based cross-sectional study.
Zibaeenejad F; Mohammadi SS; Sayadi M; Safari F; Zibaeenezhad MJ
BMC Cardiovasc Disord; 2022 Apr; 22(1):162. PubMed ID: 35397522
[TBL] [Abstract][Full Text] [Related]
2. Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort.
DeFilippis AP; Young R; McEvoy JW; Michos ED; Sandfort V; Kronmal RA; McClelland RL; Blaha MJ
Eur Heart J; 2017 Feb; 38(8):598-608. PubMed ID: 27436865
[TBL] [Abstract][Full Text] [Related]
3. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
[TBL] [Abstract][Full Text] [Related]
4. Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study.
Lindbohm JV; Sipilä PN; Mars N; Knüppel A; Pentti J; Nyberg ST; Frank P; Ahmadi-Abhari S; Brunner EJ; Shipley MJ; Singh-Manoux A; Tabak AG; Batty GD; Kivimäki M
Lancet Digit Health; 2021 Jul; 3(7):e434-e444. PubMed ID: 34167764
[TBL] [Abstract][Full Text] [Related]
5. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort.
DeFilippis AP; Young R; Carrubba CJ; McEvoy JW; Budoff MJ; Blumenthal RS; Kronmal RA; McClelland RL; Nasir K; Blaha MJ
Ann Intern Med; 2015 Feb; 162(4):266-75. PubMed ID: 25686167
[TBL] [Abstract][Full Text] [Related]
6. The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough?
Ozen G; Sunbul M; Atagunduz P; Direskeneli H; Tigen K; Inanc N
Rheumatology (Oxford); 2016 Mar; 55(3):513-22. PubMed ID: 26472565
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
Mosepele M; Hemphill LC; Palai T; Nkele I; Bennett K; Lockman S; Triant VA
PLoS One; 2017; 12(2):e0172897. PubMed ID: 28235058
[TBL] [Abstract][Full Text] [Related]
8. Assessing Level of Agreement for Atherosclerotic Cardiovascular Disease Risk Categorization Between Coronary Artery Calcium Score and the American College of Cardiology/American Heart Association Cardiovascular Prevention Guidelines and the Potential Impact on Treatment Recommendations.
Isma'eel H; Min D; Al-Shaar L; Hachamovitch R; Halliburton S; Gentry J; Griffin B; Schoenhagen P; Phelan D
Am J Cardiol; 2016 Nov; 118(10):1480-1485. PubMed ID: 27642113
[TBL] [Abstract][Full Text] [Related]
9. The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study.
Hadaegh F; Asgari S; Moosaie F; Orangi M; Sarvghadi F; Khalili D; Azizi F
J Transl Med; 2021 Jan; 19(1):25. PubMed ID: 33407576
[TBL] [Abstract][Full Text] [Related]
10. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Elevated Cardiovascular Risks in Young Adults: A Cross-sectional Analysis of National Health and Nutrition Examination Surveys.
Patel KK; Taksler GB; Hu B; Rothberg MB
Ann Intern Med; 2017 Jun; 166(12):876-882. PubMed ID: 28505660
[TBL] [Abstract][Full Text] [Related]
12. Atherosclerotic Cardiovascular Disease in Diabetes Patients.
Amelia R; Sari Wahyuni A; Yunanda Y; Wijaya H
Curr Diabetes Rev; 2023; 19(8):e060223213457. PubMed ID: 36748224
[TBL] [Abstract][Full Text] [Related]
13. A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk scores in a Southern European cohort.
Santos-Ferreira C; Baptista R; Oliveira-Santos M; Moura JP; Gonçalves L
BMC Cardiovasc Disord; 2020 Jun; 20(1):301. PubMed ID: 32560700
[TBL] [Abstract][Full Text] [Related]
14. Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy.
Mortensen MB; Afzal S; Nordestgaard BG; Falk E
J Am Coll Cardiol; 2015 Dec; 66(24):2699-2709. PubMed ID: 26700832
[TBL] [Abstract][Full Text] [Related]
15. ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
Mortensen MB; Nordestgaard BG; Afzal S; Falk E
Eur Heart J; 2017 Feb; 38(8):586-594. PubMed ID: 28363217
[TBL] [Abstract][Full Text] [Related]
16. Assessment of 2013 AHA/ACC ASCVD risk scores with behavioral characteristics of an urban cohort in India: Preliminary analysis of Noncommunicable disease Initiatives and Research at AMrita (NIRAM) study.
Menon VP; Edathadathil F; Sathyapalan D; Moni M; Don A; Balachandran S; Pushpa B; Prasanna P; Sivaram N; Nair A; Vinod N; Jayaprasad R; Menon V
Medicine (Baltimore); 2016 Dec; 95(49):e5542. PubMed ID: 27930551
[TBL] [Abstract][Full Text] [Related]
17. Discrimination between Obstructive Coronary Artery Disease and Cardiac Syndrome X in Women with Typical Angina and Positive Exercise Test; Utility of Cardiovascular Risk Calculators.
Saadat M; Masoudkabir F; Afarideh M; Ghodsi S; Vasheghani-Farahani A
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30646563
[No Abstract] [Full Text] [Related]
18. The ACC/AHA 2013 pooled cohort equations compared to a Korean Risk Prediction Model for atherosclerotic cardiovascular disease.
Jung KJ; Jang Y; Oh DJ; Oh BH; Lee SH; Park SW; Seung KB; Kim HK; Yun YD; Choi SH; Sung J; Lee TY; Kim SH; Koh SB; Kim MC; Chang Kim H; Kimm H; Nam C; Park S; Jee SH
Atherosclerosis; 2015 Sep; 242(1):367-75. PubMed ID: 26255683
[TBL] [Abstract][Full Text] [Related]
19. Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines.
Marston NA; Bonaca MP; Jarolim P; Goodrich EL; Bhatt DL; Steg PG; Cohen M; Storey RF; Johanson P; Wiviott SD; Braunwald E; Sabatine MS; Morrow DA
JAMA Cardiol; 2020 Nov; 5(11):1255-1262. PubMed ID: 32756916
[TBL] [Abstract][Full Text] [Related]
20. Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Wilson PWF; Polonsky TS; Miedema MD; Khera A; Kosinski AS; Kuvin JT
J Am Coll Cardiol; 2019 Jun; 73(24):3210-3227. PubMed ID: 30423394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]